Clinical Trial Update: FAPI-PET Value for the Initial Screening of Pancreatic and Biliary Cancers [Phase 2]

View source ↗

Summary

A Phase 2 study investigating the use of FAPI-PET imaging for initial screening of cholangiocarcinoma and pancreatic adenocarcinoma, status not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cholangiocarcinoma
• Pancreatic Adenocarcinoma

Drugs mentioned

• FAPI-PET imaging tracer (Fibroblast Activation Protein Inhibitor (FAPI))

Snippet

Sponsor: University Hospital, Bordeaux | Conditions: Cholangiocarcinoma, Pancreatic Adenocarcinoma | Phase 2 | Status: NOT_YET_RECRUITING